XML 84 R73.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation - Summary of Grants of Performance-Based Restricted Stock Units Associated with Senior Executives and Key Employees (Detail) - Performance Based Restricted Stock Units [Member] - $ / shares
Aug. 10, 2022
Jul. 22, 2021
Senior Executives [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Performance-Based Restricted Stock Units Awarded [1],[2] 178,714 122,476
Price Per Share [2] $ 5.77 [3] $ 15.93 [4]
Vesting Period [2] 3 years 3 years
Key Employees [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Performance-Based Restricted Stock Units Awarded [1],[5]   20,500
Price Per Share [5],[6]   $ 14.75
Vesting Period [5]   3 years
[1] Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements.
[2] Performance-based restricted stock units awarded to senior executives.
[3] Price per share represents the fair market value per share ($1.14 per $1, or an increase of $0.71 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($5.06) for the performance-based component of the performance-based restricted stock units granted to senior executives on August 10, 2022.
[4] Price per share represents the fair market value per share ($1.08 per $1, or an increase of $1.18 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($14.75) for the performance-based component of the performance-based restricted stock units granted to senior executives on July 22, 2021.
[5] Performance-based restricted stock units awarded to key employees.
[6] Price per share represents the closing price of our common stock on the date of grant.